Pharmacotherapy for the management of overweight and obesity
Semaglutide acts through GLP1 signaling, while cagrilintide acts through amylin signaling
GLP-1 receptor agonists like semaglutide and liraglutide, and dual GIP/GLP-1 receptor agonists like tirzepatide, slow gastric emptying, reduce appetite, and improve insulin sensitivity
Your body will readjust to changes in gut motility and appetite signals, which may temporarily influence histamine tolerance in either direction
This effect is believed to occur through the activation of tissue inhibitors of matrix metalloproteinases, natural inhibitors of MMPs [34]
Always confirm your specific pharmacy's stability documentation, as different compounders may have slightly different timeframes based on their formulation approach